Brief: Biolase Reports Q3 Loss Per Share Of $0.02
Nov 10 (Reuters) - BIOLASE Inc BIOL.O :
* SEES Q4 2021 REVENUE ABOVE Q4 2019 REVENUE OF $10.2
MILLION
* BIOLASE REPORTS 46% REVENUE GROWTH IN 2021 THIRD QUARTER;
DEMAND
FOR DENTAL LASERS FROM NEW CUSTOMERS REMAINS HIGH AND CONTINUES
TO FUEL GROWTH
* Q3 LOSS PER SHARE $0.02
* Q3 REVENUE ROSE 46 PERCENT TO $9.5 MILLION
Further company coverage: BIOL.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on November 26
See all newsBrief: BIOLASE Inc Says Nasdaq Notified Co That It Determined To Delist Co's Common Stock
U.S. RESEARCH ROUNDUP-Asana, GE Vernova, New Gold
Biolase Inc Reports Results For The Quarter Ended In March: Earnings Summary
Biolase Inc Expected To Post A Loss Of 17 Cents A Share: Earnings Preview
Biolase Inc Expected To Post A Loss Of 17 Cents A Share: Earnings Preview